Adverum Biotechnologies, Inc. ( ADVM) - Key Metrics
Stock symbol ADVM is outdated, potentially delisted? Maybe it is available on other exchange?
ADVM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0.05 | -$1.30 | -$1.01 | -$1.02 |
| 2024Q2 | ? | -$0.89 | -$0.95 | -$0.95 |
| 2024Q1 | ? | -$1.50 | -$1.41 | -$1.42 |
| 2023Q4 | -$0.36 | -$2.34 | -$2.11 | -$2.13 |
| 2023Q3 | ? | -$3.26 | -$2.37 | -$2.42 |
ADVM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | ? | -1.35 |
| 2024Q2 | ? | -1.97 |
| 2024Q1 | ? | -2.31 |
| 2023Q4 | ? | -0.80 |
| 2023Q3 | ? | -1.15 |
ADVM
Price: $4.36
52 week price:
Earnings Per Share: -8.57 USD
P/E Ratio: -0.49
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 198800
Ebitda: -14.0 millionMarket Capitalization: 92.1 million